Case Study:
Finding New Insights Why Physicians Are Increasing or Decreasing their Prescribing of a Specific Brand Using AI
Finding New Insights Why Physicians Are Increasing or Decreasing their Prescribing of a Specific Brand Using AI
The Client
The client had conducted market research but it failed to explain some of the increases and decreases seen and they wanted to get a more granular real world data insight into some of the prescribing changes seen.
The Solution
They decided to turn to Artificial Intelligence to see if real world data could explain some of the things seen. We were able to access Prescribing data by physician on a monthly basis. On top of that we also had claims data which we could link to the physician, as well as physician profile data from AMA. This combination of data allowed us to find patterns in the data that shed some light on some of the prescribing changes. For example some physicians were constrained by their health plans which impacted this client brand, some geographic locations led to higher prescribing on brands (and we were able to then look at company internal data to understand some of the reasons behind this based on their activity),
The Outcome
A clearer understanding of some of the prescribing behaviour could be identified and the company then could develop plans to address them.
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
The Future of AI Is Living Intelligence – Here’s Why You Need It
What Is Living Intelligence in AI and Why Does It Matter for the Future? In the rapidly changing world of pharmaceuticals today, AI systems that
Artificial Intelligence is on the C Suite Agenda – but Ineffectively Implemented
It is good to finally see that big data and Artificial Intelligence analytics are now on the pharma C-Suite agenda with a recent survey by NewVantage Partners showing that 85.5% of major corporations are working on big data initiatives. This is because many companies have now measured and proven the value of these for growing their pharma brands and companies.
AI + Smart Devices: The New Frontline Against Chronic Disease
Chronic diseases have emerged as one of the most significant public health challenges of the 21st century. According to the World Health Organization, chronic diseases